AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-BUSINESS SERVICES, NEC
OptimizeRx Corporation Common Stock
XNAS · usd
SIC 7389 · SERVICES-BUSINESS SERVICES, NEC
FIGI BBG001S999P1
9.15▲ 0.07 (0.77%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
9.08
Day's Range
8.89 – 9.31
52-Week Range
4.54 – 22.25
Volume
77.1K
Avg Volume
160.5K
Share Statistics
Shares Outstanding
Employees
105
Exchange
XNAS
Listed
1996-10-22
Share count as of July 30, 2026

OptimizeRx Corporation Common Stock (OPRX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about OptimizeRx Corporation Common Stock (OPRX)
What is OptimizeRx Corporation Common Stock's Market Cap?
OptimizeRx Corporation Common Stock's Market Cap is $172.3M, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Enterprise Value?
OptimizeRx Corporation Common Stock's Enterprise Value is $167.3M, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Trailing P/E?
OptimizeRx Corporation Common Stock's Trailing P/E is 37.5×, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Price / Sales?
OptimizeRx Corporation Common Stock's Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's EV / Revenue?
OptimizeRx Corporation Common Stock's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's EV / EBITDA?
OptimizeRx Corporation Common Stock's EV / EBITDA is 11.0×, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Revenue (TTM)?
OptimizeRx Corporation Common Stock's Revenue (TTM) is $98.7M, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Net Income (TTM)?
OptimizeRx Corporation Common Stock's Net Income (TTM) is $4.6M, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's EBITDA?
OptimizeRx Corporation Common Stock's EBITDA is $15.2M, based on as-reported figures from SEC (XBRL) filings.
What is OptimizeRx Corporation Common Stock's Diluted EPS (TTM)?
OptimizeRx Corporation Common Stock's Diluted EPS (TTM) is 0.24, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · OPRXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenue
YoY growth-29.8%-9.5%-0.2%+22.3%
Expenses
Cost of revenues, exclusive of depreciation and amortization presented separately below
Sales and marketing——
General and administrative—
Research and development——
Stock-based compensation——
Depreciation and amortization
Total expenses——
% of revenue100.4%98.0%——
Income from operations
% of revenue-0.4%2.0%26.6%7.9%
Other income (expense)
Interest expense
Other income
Interest income
Total other expenses, net
Income (loss) before provision for income taxes
Income tax benefit (expense)
Net income (loss)
% of revenue-3.4%-2.5%15.6%3.0%
Income (loss) per share – basic (in dollars per share)
Income (loss) per share – diluted (in dollars per share)